Correction To: Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma in Patients With Rheumatoid Arthritis: A Focus on Activity Scores (Clinical Rheumatology, (2021), 40, 10, (4019-4026), 10.1007/S10067-021-05771-Y)

Correction To: Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma in Patients With Rheumatoid Arthritis: A Focus on Activity Scores (Clinical Rheumatology, (2021), 40, 10, (4019-4026), 10.1007/S10067-021-05771-Y) Publisher Pubmed

Najafizadeh SR¹ ; Amiri K¹ ; Moghaddassi M¹ ; Khanmohammadi S¹ ; Mirmiranpour H² ; Nakhjavani M³

Show Affiliations

1. Rheumatology Research Center, Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran
2. Department of Clinical Biochemistry, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
3. Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran

Source: Clinical Rheumatology Published:2021

Abstract

In the original published version of this article, a typographical error on co-author’s first name has been changed from Shagayegh Khanmohammadi to “Shaghayegh Khanmohammadi”. The original article has been corrected. © International League of Associations for Rheumatology (ILAR) 2021

Style	Citing Format
MLA	Najafizadeh SR, et al.. "Correction To: Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma in Patients With Rheumatoid Arthritis: A Focus on Activity Scores (Clinical Rheumatology, (2021), 40, 10, (4019-4026), 10.1007/S10067-021-05771-Y)." Clinical Rheumatology, vol. 40, no. 10, 2021, pp. 4027-.
APA	Najafizadeh SR, Amiri K, Moghaddassi M, Khanmohammadi S, Mirmiranpour H, Nakhjavani M (2021). Correction To: Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma in Patients With Rheumatoid Arthritis: A Focus on Activity Scores (Clinical Rheumatology, (2021), 40, 10, (4019-4026), 10.1007/S10067-021-05771-Y). Clinical Rheumatology, 40(10), 4027-.
Chicago	Najafizadeh SR, Amiri K, Moghaddassi M, Khanmohammadi S, Mirmiranpour H, Nakhjavani M. "Correction To: Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma in Patients With Rheumatoid Arthritis: A Focus on Activity Scores (Clinical Rheumatology, (2021), 40, 10, (4019-4026), 10.1007/S10067-021-05771-Y)." Clinical Rheumatology 40, no. 10 (2021): 4027-.
Harvard	Najafizadeh SR et al. (2021) 'Correction To: Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma in Patients With Rheumatoid Arthritis: A Focus on Activity Scores (Clinical Rheumatology, (2021), 40, 10, (4019-4026), 10.1007/S10067-021-05771-Y)', Clinical Rheumatology, 40(10), pp. 4027-.
Vancouver	Najafizadeh SR, Amiri K, Moghaddassi M, Khanmohammadi S, Mirmiranpour H, Nakhjavani M. Correction To: Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma in Patients With Rheumatoid Arthritis: A Focus on Activity Scores (Clinical Rheumatology, (2021), 40, 10, (4019-4026), 10.1007/S10067-021-05771-Y). Clinical Rheumatology. 2021;40(10):4027-.
BibTex	@article{ author = {Najafizadeh SR and Amiri K and Moghaddassi M and Khanmohammadi S and Mirmiranpour H and Nakhjavani M}, title = {Correction To: Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma in Patients With Rheumatoid Arthritis: A Focus on Activity Scores (Clinical Rheumatology, (2021), 40, 10, (4019-4026), 10.1007/S10067-021-05771-Y)}, journal = {Clinical Rheumatology}, volume = {40}, number = {10}, pages = {4027-}, year = {2021} }
RIS	TY - JOUR AU - Najafizadeh SR AU - Amiri K AU - Moghaddassi M AU - Khanmohammadi S AU - Mirmiranpour H AU - Nakhjavani M TI - Correction To: Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma in Patients With Rheumatoid Arthritis: A Focus on Activity Scores (Clinical Rheumatology, (2021), 40, 10, (4019-4026), 10.1007/S10067-021-05771-Y) JO - Clinical Rheumatology VL - 40 IS - 10 SP - 4027 EP - PY - 2021 ER -

Style

Citing Format

MLA

Najafizadeh SR, et al.. "Correction To: Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma in Patients With Rheumatoid Arthritis: A Focus on Activity Scores (Clinical Rheumatology, (2021), 40, 10, (4019-4026), 10.1007/S10067-021-05771-Y)." Clinical Rheumatology, vol. 40, no. 10, 2021, pp. 4027-.

APA

Najafizadeh SR, Amiri K, Moghaddassi M, Khanmohammadi S, Mirmiranpour H, Nakhjavani M (2021). Correction To: Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma in Patients With Rheumatoid Arthritis: A Focus on Activity Scores (Clinical Rheumatology, (2021), 40, 10, (4019-4026), 10.1007/S10067-021-05771-Y). Clinical Rheumatology, 40(10), 4027-.

Chicago

Najafizadeh SR, Amiri K, Moghaddassi M, Khanmohammadi S, Mirmiranpour H, Nakhjavani M. "Correction To: Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma in Patients With Rheumatoid Arthritis: A Focus on Activity Scores (Clinical Rheumatology, (2021), 40, 10, (4019-4026), 10.1007/S10067-021-05771-Y)." Clinical Rheumatology 40, no. 10 (2021): 4027-.

Harvard

Najafizadeh SR et al. (2021) 'Correction To: Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma in Patients With Rheumatoid Arthritis: A Focus on Activity Scores (Clinical Rheumatology, (2021), 40, 10, (4019-4026), 10.1007/S10067-021-05771-Y)', Clinical Rheumatology, 40(10), pp. 4027-.

Vancouver

Najafizadeh SR, Amiri K, Moghaddassi M, Khanmohammadi S, Mirmiranpour H, Nakhjavani M. Correction To: Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma in Patients With Rheumatoid Arthritis: A Focus on Activity Scores (Clinical Rheumatology, (2021), 40, 10, (4019-4026), 10.1007/S10067-021-05771-Y). Clinical Rheumatology. 2021;40(10):4027-.

BibTex

@article{ author = {Najafizadeh SR and Amiri K and Moghaddassi M and Khanmohammadi S and Mirmiranpour H and Nakhjavani M}, title = {Correction To: Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma in Patients With Rheumatoid Arthritis: A Focus on Activity Scores (Clinical Rheumatology, (2021), 40, 10, (4019-4026), 10.1007/S10067-021-05771-Y)}, journal = {Clinical Rheumatology}, volume = {40}, number = {10}, pages = {4027-}, year = {2021} }

RIS

TY - JOUR
AU - Najafizadeh SR
AU - Amiri K
AU - Moghaddassi M
AU - Khanmohammadi S
AU - Mirmiranpour H
AU - Nakhjavani M
TI - Correction To: Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma in Patients With Rheumatoid Arthritis: A Focus on Activity Scores (Clinical Rheumatology, (2021), 40, 10, (4019-4026), 10.1007/S10067-021-05771-Y)
JO - Clinical Rheumatology
VL - 40
IS - 10
SP - 4027
EP -
PY - 2021
ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract